Anton C. Bizzell, MD

Read the latest published articles and insights from Dr. Bizzell.

Anton C. Bizzell, MD


Anton C. Bizzell, MD, a physician entrepreneur, is President & Chief Executive Officer of Bizzell, a strategy, consulting, and technology firm that delivers data-driven, research-informed, innovative solutions to the world’s most complex health, economic, security, and sustainability challenges. Dr. Bizzell also serves as the President of the Bizzell family of companies, including the Bizzell Foundation.

Dr. Bizzell is an engaging and sought-after speaker on a broad range of current issues facing the American public such as health care disparities, access, quality, behavioral health and substance use disorders prevention, treatment, and recovery. While serving as a Fellow for the U.S. Chamber of Commerce Foundation (2018-2019), Dr. Bizzell toured cities across the U.S. and engaged in conversations with state and local chambers to share innovative employer and business solutions and community partnerships in the battle against the opioid epidemic. He is a small business development leader and mentor, and an expert on community engagement and integration in lasting change.

Dr. Bizzell has continued to expand the Bizzell family of companies as a change leader, with an energizing vision for diversifying the company’s capabilities in high-impact fields. Starting with its passion to improve lives, Bizzell US has evolved to lead the way in some of the most exciting and critical issues of our time, including training thousands of opioid treatment providers, tackling the Ebola epidemic in the Democratic Republic of the Congo, creating new ways to reach U.S. military members at risk of suicide, and promoting and securing global health. Dr. Bizzell launched the Behavioral Health Advancement Resource Center in 2020, a new site with innovative resources and solutions to some of the most urgent issues of today, including the opioid epidemic, substance use disorders, suicide prevention, and the mental health impact of COVID-19. As a contributing author in Psychology Today, Dr. Bizzell shares his extensive insights in his monthly column “Mind Your Health”. The timely, impactful column promotes behavioral health and improving outcomes, with a special emphasis on public health issues like equal access to quality healthcare and mental health wellness amongst our healthcare workers. Dr. Bizzell’s influence encourages readers to embrace positive behavioral changes in their own lives as well as in the world around them. Under the leadership and vision of Dr. Bizzell, the company has grown from a staff of two in one small office to a thriving firm with multiple offices and projects around the world.

Under Dr. Bizzell’s strategic direction, the Bizzell family of companies continues to be recognized for growth, achievement, and job creation. Bizzell US, one of the fastest growing companies in America, continues to rank on Inc. Magazine’s Top 5000 List for 2020. Bizzell US (The Bizzell Group) was named to the 75 Fastest Growing Companies of 2018 and 2019 by the Washington Business Journal (WBJ). Bizzell has won five Hermes Creative Awards for visual communication and marketing projects designed to support federal agencies and corporate initiatives. Bizzell US has also been named a finalist in the 2020 U.S. Chamber of Commerce Dream Big Awards, exemplifying success and leadership in each of the following areas: business growth and performance, business strategies and goals, community engagement, customer and employee relation practices, and innovative business strategies/practices.

Dr. Bizzell has more than 25 years of combined clinical, research, health services, policy and management experiences with private and public organizations and agencies within the U.S. Department of Health and Human Services (HHS), including the Substance Abuse and Mental Health Services Administration (SAMHSA) and the National Institutes of Health (NIH). Previously, Dr. Bizzell served as a medical officer for the SAMHSA Center for Substance Abuse Treatment (CSAT) Division of Pharmacologic Therapies as well as the National Institute on Alcohol Abuse and Alcoholism within the National Institutes of Health (NIH). Dr. Bizzell led efforts in the area of prescription drug use, misuse and abuse for the agency, which includes collaborating with other federal agencies such as NIH, the Food and Drug Administration (FDA), the Drug Enforcement Administration (DEA), the White House Office of National Drug Control Policy (ONDCP) and other federal, national, state and professional organizations.

The U.S. Small Business Administration (SBA) selected Dr. Bizzell as Maryland’s Small Business Person of the Year for 2020. Dr. Bizzell serves on several boards including the Maryland Board for the March of Dimes and Alpha Phi Alpha Fraternity, Inc., where he serves as the President of the Delta Lambda Chapter in Baltimore, Maryland. In June 2020, Dr. Bizzell was appointed to the U.S. Chamber of Commerce Foundation Advisory Board which advises the U.S. Chamber of Commerce Foundation leadership on strengthening America’s long-term competitiveness and educating the public on the conditions necessary for business and communities to thrive, how business positively impacts communities, and emerging issues and creative solutions that will shape the future.

Previously, Dr. Bizzell served on the SAMHSA Center for Substance Abuse Prevention (CSAP) National Advisory Council (NAC), the Coalition on Physician Education in Substance Abuse (COPE), the National Football League’s Substance Abuse Committee, the March of Dimes-Maryland Board, the Boys and Girls Club of Greater Washington-Prince Georges County Region and several positions for Alpha Phi Alpha Fraternity, Inc., including the National Chair for the Medical Advisory Board, the Health and Wellness Committee, and the Alpha American Cancer Society Initiative.

He received his B.A in biology from the University of Virginia, his M.D. from the University of Virginia School of Medicine, and his postgraduate training in family medicine from Howard University Hospital in Washington, D.C.